Insider trading

Period: 120 months Stock: AGL Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

35 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

35 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

35 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

35 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
35 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
35 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

35 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Shaker Benjamin Chief Markets Officer
Bought
$301.05K 500,000 at 0.60
57.6%
Largest buy in 3 yrs
13 Dec 2024
McLoughlin Karen Director
Bought
$55.09K 25,000 at 2.20
51.9%
First buy on file
11 Dec 2024
Bought
$50.27K 25,062 at 2.01
61.0%
First buy on file
14 Mar 2024
Shaker Benjamin Chief Markets Officer
Bought
no price 274,455 shares
345%
First buy on file
29 Nov 2023
Bought
$250.21K 22,300 at 11.22
232%
First buy on file
21 Nov 2023
Sell Steven CEO & President · indirect
Bought
$497.74K 44,690 at 11.14
×15
Largest buy in 3 yrs
11 Sep 2023
Gertsch Timothy Chief Accounting Officer
Sold at will 2×
$488.62K 26,250 at 18.61
60.5%
Sold half or more
15 Feb 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$667.34K 28,555 at 23.37
52.7%
Sold half or more
14 Feb 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$1.15M 50,000 at 22.98
66.1%
Sold half or more
14 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$594.88K 25,881 at 22.99
71.3%
Sold half or more
2 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$707.56K 30,782 at 22.99
74.7%
Sold half or more
19 Jan 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$212.94K 10,792 at 19.73
50.9%
Sold half or more
17 Jan 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$512.23K 25,722 at 19.91
50.1%
Sold half or more
20 Oct 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 2×
$601.84K 29,548 at 20.37
53.6%
Sold half or more
8 Sep 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated 2×
$305.68K 13,490 at 22.66
55.4%
Sold half or more
21 Jul 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 2×
$1.39M 50,000 at 27.72
64.8%
Sold half or more
20 Jul 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 2×
$1.32M 50,000 at 26.38
64.6%
Sold half or more
7 Jul 2022
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$7.98M 319,071 at 25.00
53.4%
Sold half or more
5 Jul 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated 2×
$945.62K 41,187 at 22.96
79.1%
Sold half or more
25 May 2022
SMITH MICHAEL L Director · indirect
Sold, plan not stated
$2.85M 145,874 at 19.53
97.2%
Sold half or more
15 Mar 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$1.53M 79,457 at 19.25
54.4%
Sold half or more
14 Mar 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 3×
$1.67M 81,537 at 20.44
55.0%
Sold half or more
30 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$333.59K 12,113 at 27.54
69.0%
Sold half or more
27 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$153.70K 5,583 at 27.53
50.7%
Sold half or more
23 Dec 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$581.83K 21,142 at 27.52
79.6%
Sold half or more
17 Dec 2021
Danieley Joan Chief Administrative Officer
Sold, plan not stated 2×
$491.40K 21,481 at 22.88
79.8%
Sold half or more
15 Dec 2021
Danieley Joan Chief Administrative Officer
Sold, plan not stated 2×
$571.37K 25,000 at 22.85
82.1%
Sold half or more
4 Nov 2021
Sobotka Glenn Chief Accounting Officer
Sold, plan not stated
$3.78M 150,000 at 25.19
97.9%
Sold half or more
14 Sep 2021
Halkias Theodore Chief Business Officer · indirect
Sold, plan not stated
$2.90M 100,000 at 28.98
100%
Sold half or more
14 Sep 2021
Sell Steven CEO & President
Sold, plan not stated
$2.90M 100,000 at 28.98
100%
Sold half or more
14 Sep 2021
Dombro Lisa Exper. & Innovation Officer
Sold, plan not stated
$1.78M 61,543 at 28.98
83.7%
Sold half or more
14 Sep 2021
Halkias Theodore Chief Business Officer
Sold, plan not stated
$1.70M 58,553 at 28.98
91.5%
Sold half or more
14 Sep 2021
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$332.55K 11,475 at 28.98
67.9%
Sold half or more
19 Apr 2021
Richards Clay Director
Bought
$499.10K 21,700 at 23.00
312%
First buy on file
19 Apr 2021
Bought
$115.00K 5,000 at 23.00
71.9%
First buy on file
Showing 1–35 of 35.